Study title: DRY : Desmopressin Response in the Young : A double-blind, randomised, placebo-controlled, dose-titration study with three different doses (120 µg, 240 µg and 360 µg) of desmopressin administered as a new melt tablet in children and adolescents with Prim&ry Nocturnal Enuresis (PNE)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Behavior and Behavior Mechanisms [F01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DESMOPRESSIN | |||||
ATC code: | |||||
Document link: Desmopressin_FE992026 CS026_DRY.pdf | |||||
Document date: 2011-09-05 | |||||
Study number: Desmopressin_FE992026 CS026_DRY | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |